PRELIMINARY PROGRAM
Theme: Innovative Strategies Against Infectious Diseases and Emerging Immunological Disorders in Africa: Challenges and Opportunities
Pre-Congress Workshop on Flow Cytometry (7-9 December 2024)
Organizer: Benin and Gambian Immunology Societies in collaboration with Becton
Dickinson Bioscience (agenda, see Congress website https://faisctn2024.com/)
Day 1: Tuesday 10 December 2024
Registration: Begins at 7:30 AM and continues throughout the day.
Morning Session
09:30 – 10:30
The Immunology in Africa Podcast
Science communication in immunology and promotion of African immunologists
Wealth Okete (Nigeria) & Cédric Abode (Benin)
10:30 – 11:30
Benin Immunology Society meeting and activities
(for Ex Board members only)
11:30 – 12:00
Welcoming the guests and participants
Racines Group
Afternoon Session
12:00 – 13:30
Opening Ceremony
Welcome Remarks by officials (Ministry, Rectorate, Ambassador, FAIS President)
Introduction to FAIS 2024 Congress Objectives
Chairs: Steering and Local committees
13:30 – 14:30
Cocktail
14:30 – 15:00
Keynote Address: The State of Immunology in Africa
Chair: Faith Osier (Imperial College London, UK)
Speaker: Henry Mwamdumba (MLW, Malawi)
15:00 – 16:30
Plenary Session 1: Emerging and Re-emerging Infectious Diseases
Chair: Tomabu Adjobimey (UAC, Benin), Lucy Ochola (IPR, Kenya)
15:00-15:20 Tomabu Adjobimey (UAC, Benin): Immune Interplay in Emerging Infectious Diseases: Insights from Helminth Co-Infections and COVID-19 Severity Modulation
15:20-15:40 Anges Yadouleton (UAC, Benin): The contribution of genomic activities to the response to emerging and re-emerging diseases in Benin
15:40-16:00 Jason Kindrachuk (University of Manitoba, Canada): The changing epidemiology and clinical characteristics of Clade I mpox – assessments from the ongoing PHEIC
16:00-16:20 Haziz Sina (UAC, Benin): Molecular Characterization of Nosocomial Infections in Benin: Insights into Pathogen Profiles and Resistance Mechanisms
16:20-16:30 Round table discussion
16:30 – 17:00
Coffee Break
17:00 – 18:30
Parallel Session 1:
1.1: Immunology of COVID-19 and COVID-19 vaccines: Insights and Lessons from the Pandemic
Chair: Ganiyu O.Arinola (UI, Nigeria)
17:00-17:20 Ganiyu O.Arinola (UI, Nigeria): Immune responses to severe acute respiratory syndrome coronavirus-2 infection among adult Nigerians
Oral Abstracts
17:20 – 17:35 Zerrad Chaimaa (Morocco): Genetic Variations in Interferon-Induced with Helicase C Domain 1: Impact on COVID-19 Risk and Severity in the Moroccan Population
17:35 – 17:50 Faye Rokhaya (Senegal): Dynamics of SARS-CoV-2 IgG Responses and their Interaction with Seasonal Coronaviruses: Findings from a Six-Month Follow-Up Study
17:50 – 18:05 Cele Sandile (South Africa): SARS-CoV-2 Prolonged Infection during Advanced HIV Disease Evolves Extensive Immune Escape
18:05 – 18:20 Paballo Mosala (South Africa): Immunological responses of adults who are persistently negative for SARS-CoV-2 infection for 2.5 years after first outbreak in South Africa
18:20-18:30 Round table discussion
1.2 Malaria Immunology Session
Chair: Rosette Megnekou (Cameroon)
17:00 – 17:20 Robin Stephens (USA): T cell memory in Plasmodium chabaudi malaria
17:20 – 17:40 Priscilla Ngotho (UK): Characterising the dynamics of naturally acquired immunity to P. falciparum gametocytes towards reducing malaria transmission
17:40 – 18:00 James Tuju (UK): Bi-isotype immunoglobulins enhance antibody-mediated neutrophil activity against Plasmodium falciparum parasite
18:00 – 18:10 Ezinmegnon Sem (Burkina Faso): Pattern of naturally acquired antibody responses against a panel of P. falciparum antigens in children living in an area of seasonal malaria transmission of Burkina Faso
18:10 – 18:20 Nadia Domingo (USA/Benin): Microglia in Coagulation in Cerebral Malaria
18:20 – 18:30 Bertin Vianou (USA – virtual): Elevated plasma interleukin-8 as a risk factor for mortality in children presenting with cerebral malaria
1.3: Interactive round table discussion with invited experts: Kidney Transplant Immunology
Chair: Alioune Dieye (Cheikh Anta Diop University Dakar, Senegal)
17:00 – 17:20 Alioune Dieye (Senegal): Strategies and experiences from the National Council for Donation and Transplantation (CNDT), Senegal
17:20 – 17:40 Moustapha Mbow (Senegal): Building a kidney transplant immunology platform in Sub-Saharan Africa: example of Senegal
17:40 – 18:00 Sery Romuald Dasse (Ivory Coast): Importance of Establishing the Ivorian Network for Grafting and Transplantation
Oral abstract:
18:00 – 18:15 Moussa Ndour (Senegal): Study of the HLA profile in donor and recipient couples for kidney transplant in Senegal.
18:15 – 18:30 Round Table Discussion
18:30 – 20:30 Snacks, drinks and dinner: Bio Pharma presentation and discussion on the history of African Immunology: “The Past”
Day 2: Wednesday 11 December 2024
Morning Session
08:30 – 10:00
Plenary Session 2: One Health Immunology
Chair: Victorien Dougnon (UAC, Benin) and Ya-Jankey Jagne (MRC, Gambia)
8:30 – 8:50 Victorien Dougnon (Benin – virtual): To be announced
8:50 – 9:10 Baptiste Dungu (DRC): One Health Vaccinology
9:10 – 9:30 Clarissa Prazeres da Costa (Germany): Integrating the Global Health Agenda into Infection and Immunity Research
9:10 – 9:30 Round table discussion
10:00 – 10:30
Coffee Break and Exhibition Visit
10:30 – 12:05
Parallel Sessions 2
2.1: Towards Sustainable Global Health and Immunity by TUM Center for Global Health
Chair: Fabien Prodjinotho (TU, Munich, Germany)
10:30 – 10:45 Fabien Prodjinotho (Germany): Introducing the TUM Global Health Center,
Research activities and opportunities
10:45 – 11:15 Clarissa Prazeres da Costa: The Developmental Origins of Health and Disease (DOHaD) and trained immunity in Global Health
11:15 – 12:05 Interactive round table on Global health and sustainable immunity across geographical regions, including trained immunity during early life and women health
Panelists: Clarissa Prazeres da Costa (Germany), Ya-Jankey Jagne (MRC, Gambia) & Baptiste Dungu (DRC)
2.2: Integrating One Health and Immunology: A Comprehensive Approach to Global Health Challenges
Chair: Rahwa Osman (Imperial College London, UK)
10:30 – 10:50 Musa Mulongo (ILRI, Kenya): Building an R&D and commercialization framework for animal vaccines in Africa
Oral Abstracts
10:50 – 11:00 Privat Kobat Agniwo (Mali): Population genetic structure of Schistosoma bovis and S. curassoni collected from cattle in Mali
11:00 – 11:10 Georgelin Nguema Ondo: Genetic Diversity and Detection of Respiratory Viruses Excluding SARS-CoV-2 during the COVID-19 Pandemic in Gabon, 2020–2021.
11:10 – 11:20 Ahristode Barthel Akplogan (Benin/Mali): Genetic profiles of schistosomes from endemic areas of Mali
11:20 – 11:30 Sèyigbéna Prudence Déo-Gracias Berry (Germany): Helminth infections and pregnancy outcomes
11:30 – 11:40 Linda Djune Yemeli (Cameroon): Ivermectin treatment of low-to-moderate loiasis infection: assessment of microfilariae load reduction, antigens and cytokines production.
11:40 – 11:50 Johanna Ertl (Germany): Host-specific platelet-activating factor acetyhydrolase selectively remodels diacylglycerophosholipids to control schistosome development
11:50 – 12:05 Round Table Discussion
2.3: Reproductive immunity and paediatric immune ontogeny
Chair: Clive Gray (South Africa)
10:30 – 10:50 Rana Chakraborty (USA): Host-viral interactions at the maternal-fetal interface: The role of CMV-induced inflammation in HIV transmission.
10:50 – 11:05 Doty Ojwach (South Africa): Placental Macrophage Function and Vascular Development: The Impact of First-Line Antiretroviral Drugs and the Role of Exogenous FXIIIA1
11:05 – 11:20 Helen Payne (UK/SA – virtual): The spectrum of impact of in-utero exposure to CMV on infant immunity and health outcomes
11:20 – 11:35 Theresa Rossouw (South Africa): Immunometabolic aberrations in HIV-exposed uninfected infants: implications for growth and immune development
Oral abstracts
11:35 – 11:45 Walaa Jradi (Germany – Virtual): Profiling Maternal Immune Activation-Induced Alterations and Training Effects in Offspring’s Immune Cell Compartments (virtual)
11:45 – 11:55 Fatou Coulibaly Sall (Senegal): Investigation of the complement abnormalities system in child nephropathies
11:55 – 12:05 Hope Mataramvura (Zimbabwe): Natural Killer cell metabolism is altered in early-life HIV/ART exposure
12:05 – 13:30
Lunch Break and Exhibition Visit
Afternoon Session
13:30 – 15:00
Industry Session 1: Pandemic and Epidemic Preparedness
Chair: Anges Yadouleton (UAC, Benin)
13:30 – 13:40 Anges Yadouleton (Benin): Mpox
13:40 – 14:00 Nicaise NDAM (France/Benin): To be announced
14:00 – 14:20 Ange Dossou (Benin): Mpox
14:20 – 15:00 Round Table Discussion
13:30 – 15:00
Parallel Sessions 3
3.1: COVID in Africa
Chairs: Ines Vigan-Womas (Institut Pasteur de Dakar, Senegal) and Peter Kojo Quashie (WACCBIP)
13:30 – 13:50 Ines Vigan-Womas (Senegal): SARS-CoV2 response within African populations
13:50 – 14:10 Peter Kojo Quashie (Ghana): A multi-pronged experimental approach explains non-lethal COVID-19 experience in Ghana and West Africa
Oral Abstracts
14:10 – 14:20 David Otieno (Kenya): Impact of Plasmodium falciparum malaria on SARS-CoV-2 antibody responses in Kenya and Uganda (MALCOV)
14:20 – 14:30 Patrick Ndinguri (Kenya): One health parallel Seroprevalence of SARScOV2 Endemic human coronaviruses and Plasmodium falciparum in a Malaria endemic region of Kenya
14:30 – 14:40 SEUMKO’O NDEUMOU Reine (Cameroon): Malaria increases the cross-reactivity to anti-SARS-CoV-2 antibodies on lateral flow tests using pre-COVID-19 samples of pregnant women in Yaoundé.
14:40 – 14:50 Cédric ABODE (Benin – Virtual): Evaluating vaccine efficacy in Benin: Immunological responses and challenges in a low-resource setting
14:50 – 15:00 Round Table Discussion
3.2: Placental Malaria
Chair: Rafiou Adamou (CERMEL, Gabon & UAC, Benin)
13:30 – 13:50 Rosette Megnekou (Cameroon): Cellular responses, placental malaria, currently under parasites
Oral Abstracts
13:50 – 14:00 Chris Marco Nana Mbianda (Cameroon): Targeting γδ T Cells in Placental Malaria: PD1 and TIM-3 as Immunotherapy Biomarkers for Improving Pregnancy Ouctomes
14:00 – 14:10 Djelili Biaou (Benin/France: Transplacental transfer of functional antibodies against blood-stage antigens of P. falciparum in preterm newborns
14:10 – 14:20 Mahugnon Léger Erasme Gbaguidi (Brazil/Benin): Protective antibodies against P. falciparum merozoite are induced during pregnancy and early life
14:20 – 14:30 Fred Owino (Kenya): Placental Malaria Infection is Associated with Downregulation of STAT6 and ANG-1 in Decidual Macrophages
14:30 – 14:40 Alex Rotich (Kenya/Japan): Exploring PfCSA-L as an Alternative Vaccine Target for Malaria in Pregnancy: Evidence from Antibody Responses and Sequence Conservation
14:40 – 15:00 Round Table Discussion
15:00 – 16:30
Plenary Session 3: Cancer Immunology
Chair: Lucy Ochola (Kenya) and Abdalla Badou (Morocco)
15:00 – 15:20 Sumit Subudhi (USA) Strategies to Overcome the Immunosuppressive Prostate Tumor Microenvironment.
15:20 – 15:40 Abdallah Badou (Morocco): Tumor Microenvironment in Breast Cancer: Unveiling Novel Therapeutic Targets.
15:40 – 16:00 Barbara Seliger (Germany): Immune escape mechanisms as critical determinants of response to immunotherapy in cancers.
16:00 – 16:30 Round Table Discussion
16:30 – 17:00
Coffee Break
17:00 – 18:30
Parallel Sessions 4
4.1: Human Challenge session
Chair: Michael Theisen.
17:00 – 17:20 Kondwani Jambo (Malawi): The pneumococcal human challenge model in Malawi
17:20 – 17:40 Michael Theisen (Denmark): An introduction to the ProC6C vaccine candidate including results from past clinical trials
17:40 – 18:00 Issaka Sagara (Mali): Protective efficacy induced by ProC6C-AlOH/MM, a Plasmodium falciparum multi-stage malaria vaccine candidate against PfSPZ Challenge in healthy Malian adults.
Oral Abstracts
18:00 – 18:15 Muki Shey (South Africa): Immune responses to Mycobacterium tuberculosis reveals heterogeneity among individuals with apparent resistance to infection
18:15 – 18:30 Round Table Discussion
4.2. Efficacy of Traditional African Herbal Formulas and Early Nutrition on Human Immunity
Chair: Gatien Lokossou (UAC, Benin)
17:00 – 17:20 Gatien Lokossou (Benin): Accumulating data on breasfeeding: should wenow accept that breast milk is a natural vaccination against infections and non-infectious diseases?
17:20 – 17:40 Yessoufou Akadiri (Benin): Immunological modulation of diabetic pregnancy and macrosomia: role of omega-3 poly-unsaturated fatty acids (PUFA)
17:40 – 18:00 Latifou Lagnika (Benin): To be announced
Oral abstracts:
18:00 – 18:15 Ngwa Fabrice Ambe (Cameroon): Probiotic Limosilactobacillus fermentum and Enterococcus lactis isolated from Cameroonian traditionally processed milk and palm wine ameliorate neuroinflammation and chronic constriction injury-induced neuropathic pain in mice
18:15 – 18:30 Rufine Fachinan (Benin): Immunomodulatory effect of Momordica charantia: CD4+ lymphocyte differentiation and T cell activation
4.3: Innovations in B Cell Research and Antibody Therapeutics
Chair: Leopold Tientcheu (MRC, Gambia)
Oral Abstracts
17:00 – 17:15 Dawda Jobe (Gambia): Immunity to seasonal coronaviruses and cross-reactivity to SARS-CoV-2 prior to the COVID-19 pandemic in The Gambia
17:15 – 17:30 Eunice Kiamba: Human papillomavirus vaccine-induced B cell and T follicular helper cell responses by age and dose number
17:30 – 17:45 Makoutchouang Nzonde Biscotine Flore (Senegal): Evolutionary kinetics of antibody levels in a cohort vaccinated against COVID-19 in Senegal
17:45 – 18:00 Hervé Ouambo Fotso (Cameroon): Profiles of Immunoglobulin G Antibody Subclass Responses Specific to MSP3 and UB05 in Plasma of Malaria Negative Children Living in Two Different Agro-ecological Settings of Cameroon
18:00 – 18:15 Evans Asamoah Adu (Ghana): In-Silico Mining of the Schistosomula immunopeptidome for Selecting and Designing Anti-Inflammatory, Tolerogenic and Subunit Vaccine Candidates
18:15 – 18:30 Round Table Discussion
18:30 – 20:20 Snacks, drinks and dinner: Bio Pharma presentation and discussion on the history of African Immunology: “The Present”
Day 3: Thursday 12 December 2024
Morning Session
08:30 – 10:00
Plenary Session 4: HIV, TB, and Malaria
Chair: Henry Mwandumba (MLW, Malawi)
8:30 – 8:50 Patrick Duffy (NIH): The first multistage malaria vaccine
8:50 – 9:10 Clive Gray (South Africa): The Impact of HIV on the placenta and on neonatal T cell immunity
9:10 – 9:30 Kondwani Jambo (Malawi): Duodenal mucosa CD8+ T cells in African adults living with and without HIV
9:30 – 10:00 Round Table Discussion
10:00 – 10:30
Coffee Break
10:30 – 12:00
Parallel Sessions 5
5.1. IRD Malaria Symposium: Malaria in Pregnancy
Chair: Nicaise NDAM (IRD, France/Benin)
10:30 – 10:50 Justin Doritchamou (USA): Dynamics of antibody specific to the placental malaria vaccine candidate VAR2CSA during pregnancy
10:50 – 11:10 Lars Hviid (Denmark): Antigen recognition and effector function differ between naturally acquired and vaccine-induced VAR2CSA-specific IgG
11:10 – 11:30 Nicaise NDAM (France/Benin): Structure-guided approaches in the identification of transcendent VAR2CSA protective epitopes
11:30-11:40 Celia Dechavanne: Role of Plasmodium falciparum maternal infection on the modulation and functionality of neonatal Dendritic Cells
11:40-12:00 Round Table Discussion
5.2.: HIV and TB
Chair: Clive Gray (South Africa)
Oral Abstracts
10:30 – 10:45 Ivan Mwebaza (USA): Mycobacterium tuberculosis derived ManLAM disrupts the integrity of the Immunological Synapse and Dysregulates the Ubiquitin-T cell Receptor Signaling axis
10:45 – 11:00 Hleziphi Violah Mpundu (South Africa): Exploring the antimycobacterial potential of repurposed drugs
11:00 – 11:15 Forgu Esemu Livo (Cameroon): Third trimester antibody response to enteroviruses are lower in women living with HIV during pregnancy
11:15 – 11:30 Chris Andre Mbongue mikangue (Cameroon). Role of Toll-Like Receptor 2 Immune Response in patients with Mycobacterium Tuberculosis and Chronic Obstructive Pulmonary Diseases at the JAMOT Reference Hospital in Yaounde-Cameroon
11:30 – 11:45 Chaimae Kadi (Morocco). Phenotypic analysis of count, memory and activation status of lymphocytes subpopulations in Active and Latent tuberculosis
11:45 – 12:00 Round Table Discussion
5.3. Advances in T-Cell Immunology: From Basic Research to Clinical Applications including Cancer Immunology
Chair: Rafiou Adamou (CERMEL, Gabon & UAC, Benin)
Oral Abstracts
10:30 – 10:50 Samad Ibitokou (USA): iPSC-derived CAR-T cells therapy against solid cancer models.
10:50 – 11:05 Doudou Georges Massar Niang (Senegal): Blood group and genetic diversity influence on galectin-3 plasma concentrations.
11:05 – 11:20 Seun Elijah Olufemi (Nigeria): Antigenic differentially expressed proteins as precursor for mRNA vaccine against breast cancer: an insight from computational approach
11:20 – 11:35 Alya Boutabba (Tunisia): Analysis of circulating biomarkers in Tunisian lung cancer patients
11:35 – 11:50 Paulin Kpodji (Benin): Immunomodulatory activities of Acanthospermum hispidum and Croton zambesicus on IL-6 and TNFα
11:50 – 12:00 Round Table Discussion
12:00 – 13:30
Lunch Break and Poster session 1 (even numbers)
Afternoon Session
13:30 – 15:00
Session 6
6.1. Environmental factors and immunity and Diverse topics
Chair: Sabelle Jallow (South Africa)
Oral Abstracts
13:30 – 13:45 Moustapha Mbow. Footprints of the geographical difference of the immune system. Cheikh Anta Diop University of Dakar, Dakar, Senegal
13:45 – 14:00 Aina Kehinde. Isogenic hiPSC-derived liver Organoid and Organ-on-chip models: A valuable tool for infectious disease modelling. Helmholtz Centre for Infection Research, Inhoffenstrasse, 7, 38124, Braunschweig, Germany.
14:00 – 14:15 Juliet Karger (Germany): Exploring how exposure to different environments in utero contribute to the concept of transgenerational trained immunity
14:15 – 14:30 Leonel Meyo Kamguia (Cameroon/USA): Reduced plasma levels of GM-CSF is a common feature of Schistosoma mansoni-infected school-aged children
14:30 – 14:45 Emmanuel Nji: Structural biology in Africa
14:45 – 15:00 Round Table Discussion
15:00 – 16:45
Plenary Session 5: Collaboration and Funding in Immunological Research
Chair: Pa Tamba Ngom
15:00 – 15:20 Fatu Badiane, Science for Africa Foundation
15:20 – 15:40 Anh Wartel, International Vaccine Institute
15:40 – 16:00 Omonkhua Akhere (Africa Research Excellence Fund)
16:00 – 16:15 Kondwani Jambo, Wellcome Trust Grant writing initiative
16:15 – 16:45 Round Table Discussion
16.45 – 18:30
FAIS General Assembly and Executive Committee Elections (all delegates invited)
18:30 – 20:20 Snacks, drinks and dinner: Bio Pharma presentation and discussion on the history of African Immunology: “The Promise”
Day 4: Friday 13 December 2024
Morning Session
08:30 – 10:00
Plenary Session 6: Vaccine Immunology Development and Supporting Platforms
Chair: Faith Osier (Imperial College London, UK)
8:30 – 8:50 Ines Vigan-Womas (Senegal): Building an integrated R&D ecosystem to accelerate Vaccine and Diagnostic Development
8:50 – 9:10 Eleni Aklillu (Sweden): Vaccine Pharmacovigilance and Regulatory Capacity in Africa
9:10 – 9:30 Patricia Cristina da Costa Neves (Brazil): Vaccines Biomanufacturing at Bio-Manguinhos/Fiocruz
9:30 – 10:00 Round Table Discussion
10:00 – 10:30
Coffee Break
10:30 – 12:00
Parallel Sessions 7
7.1: Chanjo Hub Vaccine manufacturing symposium (UK-Vaccines Network)
Chair: Faith Osier (Imperial College London, UK)
10:30 – 10:50 David Jarvis (South Africa): Inheritance of Acquired Immunity, Lessons for Vaccinology
10:50 – 11:10 Komi Gbedande (USA): Boosting Live Malaria Vaccine with CMV Vector to Prolong Immunity
11:10 – 11:30 Eluem Blyden (USA): Egg-based vaccine manufacturing, Avril Biopharma
11:30 – 11:50 Marilena Cabral. A fast track to RNA vaccines R &D in LMICs, UNIZIMA
11:50 – 12:00 Round Table Discussion
7.2. Advancing Equity, Diversity, and Inclusion in Immunological Research
Chair: Theresa Rossouw (University of Pretoria, South Africa)
10 min each
Lucy Ochola
Doty Ojwach
Sabelle Jallow
Rosette Megnekou
Pa Tamba
Nicaise NDAM
Kondwani Jambo
11:40 – 12:00 Round Table Discussion
12:00 – 13:30
Lunch Break and Exhibition Visit – Global Development HUB (Imperial College) – sponsorship
Afternoon Session
13:30 – 15:00
Industry Session: Qiagen and Sartorius
13:30 – 14:15 Mouna Ben Sassi (Qiagen): Innovative Applications from Sample to Insight: Bridging Translational Research and Clinical Diagnostics in Africa.
14:15 – 15:00 Philipp Conradi (Sartorius): Immunotherapy Manufacturing Journey: From Bench to Bed
15:00 – 16:30
Poster session 2 (odd numbers)
16:30 – 18:00
Plenary Session 7: Allergy and Autoimmunity
Chair: Abdelilah Soussi Gounni (University of Manitoba, Canada)
16:30 – 16:50 Abdelilah Soussi Gounni (Canada): Neuronal Chemorepellent Semaphorin-3E Regulates Immune Response in Allergic Asthma
16:50 – 17:10 Jude Uzonna (Canada): Induction of Autoimmunity: it is harder than you think
17:10 – 17:30 Judith Gbènoudon (Benin): Immunity to Infectious Diseases and Allergies in the Context of Multiple Infections
17:30 – 17:45 Bineta Ndiaye (Senegal): Serological profile of organ-specific autoimmune diseases in Senegal
17:45 – 18:00 Round Table Discussion
18:00 – 19:00 Biopharma ceremony
19:00 – 19:30
Prize Ceremony and Closing Remarks
Chair: Pa Tamba Ngom (outgoing FAIS President)
19:00 – 19:15 Concluding Remarks: The Way Forward for Immunological Research and Collaboration in Africa
Festive Ending
Chair: Clive Gray (incoming FAIS President)
19:15 – 19:30 The next two years of FAIS
19:30 – 22:00
Social Event and Farewell Reception
